Successful treatment of immunoblastic lymphadenopathy-like T-cell lymphoma with cyclosporin A

Leukemia and Lymphoma

Volumn 35, Issue 3-4, 1999, Pages 389-395

  Takemori, Nobuo ^a   Kodaira, Junichi ^a   Toyoshima, Nobuyasu ^a   Sato, Teiko ^b   Sakurai, Hiroharu ^b   Akakura, Nobuaki ^c   Kimura, Shoji ^d   Katagiri, Makoto ^d  

^a Department of Internal Medicine ^*  (Japan)

^b Asahikawa Kosei General Hospital   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Cyclosporin A; IBL like T cell lymphoma; Remission; Treatment

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOMODULATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; T CELL LYMPHOMA;

EID: 0032708286     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145744     Document Type: Article

References (29)

1. Frizzera, G., Moran, E.M., and Rappaport, H. (1974). Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet, i, 1070-1073.
2. Lukes, R.J. and Tindle, B.H. (1975). Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin's disease. New England Journal of Medicine, 292, 1-8.
3. Shimoyama, M., Minato, K., Saito, H., Takenaka, T., Watanabe, S., Nagatani, T. and Naruto, M. (1979). Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma. Japanese Journal of Clinical Oncology, 9 (Suppl.), 347-356.
4. Tobinai, K., Minato, K., Ohtsu, T., Mukai, K., Kagami, Y., Miwa, M., Watanabe, S. and Shimoyama, M. (1988). Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Biood, 12, 1000-1006.
5. Watanabe, S., Sato, Y., Shimoyama, M., Minato, K. and Shimosato, Y. (1986). Immunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy, and IBL-like T-cell lymphoma: a spectrum of T-cell neoplasia. Cancer, 58, 2224-2232.
6. Murayama, T., Imoto, S., Takahashi, T., Ito, M., Matozaki, S. and Nakagawa, T. (1992). Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A. Cancer, 69, 2567-2570.
7. Theodorou, I., Raphaël, M., Bigorgne, C., Fourcade, C., Lahet, C., Cochet, G., Lefranc, M.-P., Gaulard, P. and Farcet, J.-P. (1994). Recombination pattern of the TCR γ locus in human peripheral T-cell lymphomas. Journal of Pathology, 174, 233-242.
8. Sigal, N. H. and Dumont, F.J. (1992). Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annual Review of Immunology, 10, 519-560.
9. Schreiber, S.L. and Crabtree, G.R. (1992). The mechanism of action of cyclosporin A and FK506. Immunology Today, 13, 136-142.
10. Kahan, B.D. (1993). Immunosuppressive agents acting upon lymphokine synthesis and signal transduction. Clinical Transplantation, 7, 113-125.
11. Hess, A.D. (1994). Cellular immunobiology of cyclosporin A. In Immunosuppressive drugs: developments in anti-rejection therapy, edited by A.W. Thompson and T. Starzl, pp. 47-62. London, Edward Arnold.
12. Reem, G.H., Cook, L.A. and Vilček, J. (1983). Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science, 221, 63-65.
13. Andersson, J., Nagy, S., Groth, C.-G. and Andersson, U. (1992). Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 75, 136-142.
14. Costello, R., Mawas, C. and Olive, D. (1993). Differential immuno-suppressive effects of metabolic inhibitors on T-lymphoeyte activation. European Cytokine Network, 4, 139-146.
15. Han, C.-W., Imamura, M., Hashino, S., Zhu, X., Tanaka, J., Imai, K., Matsudaira, T. and Asano, S. (1995). Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. Bone Marrow Transplantation, 15, 733-739.
16. Fukuzawa, M. and Shearer G.M. (1989). Effect of cyclosporin A on T cell immunity: I. Dose-dependent suppression of different murine T helper cell pathways. European Journal of Immunology, 19, 49-56.
17. Wheeler, D.J., Robins, A., Pritchard, D.I., Bundick, R. V. and Shakib, F. (1995). Potentiation of in vitro synthesis of human IgE by cyclosporin A (CsA). Clinical and Experimental Immunology, 102, 85-90.
18. Bundick, R.V., Craggs, R.I. and Holness, E. (1995). The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response - an in vivo model of Th2-like activity. Clinical and Experimental Immunology, 99, 467-472.
19. Ohnishi, K., Ichikawa, A., Kagami, Y., Nagasaka, T., Niwa, T., Hotta, T. and Saito, H. (1990). Interleukin 4 and γ-interferon may play a role in the histopathogenesis of peripheral T-cell lymphoma. Cancer Research, 50, 8028-8033.
20. Merz, H., Fliedner, A., Orscheschek, K., Binder, Th., Sebald, W., Müller-Hermelink, H. K. and Feller, A.C. (1991). Cytokine expression in T-cell lymphomas and Hodgkin's disease. American Journal of Pathology, 139, 1173-1180.
21. Hsu, S.-M., Waldron Jr., J.A., Fink, L., King, C., Xie, S.-S., Mansouri, A. and Barlogie, B. (1993). Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. Human Pathology, 24, 126-131.
22. Kato, H., Nagasaka, T., Ichikawa, A., Kinoshita, T., Murate, T., Tsushita, K., Hotta, T. and Saito, H. (1994). Tumor necrosis factor-β gene expression and its relationship to the clinical features and histopathogenesis of peripheral T-cell lymphomas. Leukemia and Lymphoma, 16, 125-133.
23. Foss, H.-D., Anagnostopoulos, I., Herbst, H., Grebe, M., Ziemann, K., Hummel, M. and Stein, H. (1995). Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood, 85, 2862-2869.
24. Takeshita, M., Sumiyoshi, Y., Masuda, Y., Ohshimu, K., Yoshida, T., Kikuchi, M. and Müller, H. (1993). Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma. Pathology, Research and Practice, 189, 18-25.
25. Trinchieri, G. (1994). Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood, 84, 4008-4027.
26. Kita, H., Ohnishi, T., Okubo, Y., Weiler, D., Abrams, J.S. and Gleich, G.J. (1991). Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. Journal of Experimental Medicine, 174, 745-748.
27. Cirillo, R., Triggiani, M., Siri, L., Ciccarelli, A., Pettit, G.R., Condorelli, M. and Marone, G. (1990). Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. Journal of Immunology, 144, 3891-3897.
28. Hatfield, S.M. and Roehm, N. W. (1992). Cyclosporine and FK506 inhibition of murine mast cell cytokine production. Journal of Pharmacology and Experimental Therapeutics, 260, 680-688.
29. Ito, C., Ribeiro, R.C., Behm, F. G., Raimondi, S.C., Pui, C.-H. and Campana, D. (1998). Cyclosporin A induces apoptosis in childhood acute lymphohlastic leukemia cells. Blood, 91, 1001-1007.